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Abstract
Background: Information about trends in perinatal and child health inequalities is scarce, especially in the Eastern
Europe. We analyzed how mortality under 1 year of age has been changing in the Baltic States and the European
Union (EU) over 25 years, and what associations occurred between changes in macroeconomic factors and
mortality.
Methods: Data on fetal, neonatal, infant mortality, and macroeconomic factors were extracted from WHO database.
Joinpoint regression analysis was performed to analyze time trajectories of mortality over 1990–2014. We also
investigated how the changes in health expenditures and Gross Domestic Product (GDP) contributed to the
changes in mortality.
Results: The reduction of fetal, neonatal and infant mortality in the Baltic countries led to convergence with the
EU. In Estonia this process was the fastest, and then the rates tended to diverge. The strongest effect in reduction
of neonatal mortality was related to the annual increase in health expenditure and GDP which had occurred in the
same year, and a decrease in fetal mortality associated with an increase in health expenditure and GDP in the 4th
and 5th year, respectively, following the initial change.
Conclusions: These findings outlined convergences and divergences in mortality under 1 year of age in the Baltic
States compared with the patterns of the EU. Our data highlighted a need to define health policy directions aimed
at the implementation of effective intervention modalities addressing reduction of risks in prenatal and early life.
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Background
Mortality rates under 1 year of age, as the most severe ad-
verse birth outcomes, are important indicators of population
health and the distribution of human welfare. They are also
regarded as useful measures of the quality of health care for
mother and child [1, 2]. In developed countries, a significant
decrease has been reported in the indices of fetal, neonatal
and infant mortality during recent decades. This trend was
associated with not only an improved prenatal care and ad-
vanced perinatal care, but also with a large-scale implemen-
tation of oxygen therapy, and predominant use of
corticosteroids and antibiotics [3, 4]. Though the situation
has been considerably improved, the mortality under 1 year
of age still confers an important public health challenge.
In the European Union (EU), mortality under 1 year of age
is the lowest in the world [5, 6]. However, inequalities in peri-
natal and child health between individual member countries
continue to be reported. In general, the highest mortality rates
were approximately 4-fold higher than the lowest ones. Given
that in 2014 fetal mortality rates ranged from 2.7 to 10.2 per
1000 total births, whereas infant mortality rates ranged from
2.0 to 8.1 per 1000 live births [7]. Cross-comparisons between
countries within the EU may be difficult at the methodological
level as there are essential individual differences in registration
criteria used for live births and stillbirths. Nevertheless, the
proportions of mortality remain even when these differences
are taken into account [8–10]. The adverse birth outcomes
were reported particularly in Central and Eastern European
populations in comparison toWestern countries. The inequal-
ities in perinatal and child health require a special focus in the
Baltic States (Estonia, Latvia, and Lithuania) which demon-
strate a unique background and offer special conditions for
evaluation of health outcomes.
The three Baltic States underwent a systemic change and
became reorganized in the early 90’s of the twentieth century
when the states gained independence after the fall of the
Communist regime in the Soviet Union. Although the trans-
formation process from socialism into the market economy
was similar in the region and took place within a short time-
period, the socio-economic conditions had been variable and
differed across individual countries [11, 12]. The
denationalization and liberalizing of the economy in Estonia
progressed much faster than in other Baltic countries, and
the process has resulted in increasing inequalities between
countries in the region. In Latvia the precipitate changes re-
garding reconstructing of the industry and increasing un-
employment occurred in the mid 90’s. Contrastingly,
Lithuania was proceeding with the stepwise economic
changes gradually within a longer time [12, 13]. Along with
differing living conditions, there were significant differences
in health care provisions and standards. The changes and
fluctuations also had an impact on women’s health and re-
productive health and subsequently they affected fetal, neo-
natal and infantile health status [14].
In order to assess the trajectories of perinatal and child
health in the Baltic states within the last 25 years, the data
derived from World Health Organization (WHO) and
core indicators provided by Euro-Peristat were used [15].
Noticeably, in the early 90’s the rates of mortality under 1
year of age were high in all Baltic countries and thereby
the decrease of the indices was faster. We hypothesized
that the level of mortality under 1 year of age in the Baltic
states may become similar to the average level typically
found in the developed EU countries. The European
Union may serve as an appropriate comparator because
the large numbers of live births reaching about 5 million
per year ensure a good reliability of the analyses [5, 7]. In
this study, we analyzed how mortality under 1 year of age
has been changing in the Baltic States and the European
Union over 25 years, and what associations occurred be-
tween changes in macroeconomic factors and mortality.
Material and methods
This study was performed according to the mortality
under 1 year of age in Estonia, Latvia, Lithuania and EU
members for the period 1990-2014. We analyzed the
rates of mortality for the most recent data, which was
available for the Baltic countries and the EU in the same
years (from 1990 or 1991 to 2014). This data is based on
perinatal death certification and medical death certifica-
tion and updated annually from national civil registra-
tion systems. The quality data of mortality under 1 year
of age has been evaluated by the WHO [16].
The general concept for the analysis were indicators
approved and used by the Euro-Peristat [15]; this being
an essential part of the EU’s Health Monitoring
Programme and now has representation from 31 coun-
tries across Europe and a network of experts. Core indi-
cators estimating perinatal and child health were
included in the analysis along with patterns of mortality
under 1 year of age. For example:
(C1) Fetal mortality rate is the number of fetal deaths
at or after 22 completed weeks of gestation in a given
year per 1000 live and stillbirths in the same year.
For comparisons in fetal mortality rates between
Baltic countries and the EU, the estimated mean fetal
mortality rate was derived from 16 European states in
which the registration criteria for fetal death are
lower or equal to 22 weeks of gestation age. The in-
clusion of 16 EU countries (i.e. Austria, Czech Repub-
lic, Denmark, Estonia, Finland, Germany, Hungary,
Ireland, Italy, Latvia, Lithuania, Netherlands, Poland,
Portugal, Slovenia, and United Kingdom) led to a
more reliable and accurate estimation of fetal mortal-
ity rates [17].
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(C2) Neonatal mortality rate - the number of neonatal
deaths (day 0 through 27) after live birth in a given year
per 1000 live births in the same year.
(C3) Infant mortality rate - the number of deaths (day
0-364) after live birth in a given year per 1000 live
births in the same year.
The rates C2 and C3 were presented for all births at
or after 22 completed weeks of gestation.
To evaluate the effect of the macroeconomic situation in
EU countries on mortality, we included data on total health
expenditures and Gross Domestic Product (GDP) measured
per capita. We defined total health expenditures as current
spending by both public and private sources on medical ser-
vices and goods, public health and prevention programmes,
and administration, expressed in Purchasing Power Parity
(PPP) in US dollars [6]. GDP represents the sum of gross
value added by all resident producers in the economy plus
any product taxes and minus any subsidies not included in
the value of the product, expressed in current international
United States dollars (US$) [7]. We have studied the rela-
tionship between mortality under 1 year of age, and macro-
economic factors since 1995 due to a lack of data on health
expenditures over 1990-1994. Comparable data for indicators
of perinatal and child health, and macroeconomic situation
were obtained from WHO European Health Information
Gateway – Health for All explorer [7].
Statistical analysis
To examine the changes associated with mortality under 1
year of age during the last 25 years, the Joinpoint regression
analysis was performed allowing for significant changes in
trends during the period to be detected. The applied analytic
method automatically identified number and locations of
Joinpoints during the observation period, restricting their
number to 3, resulting in up to 4 linear segments in trend
line. Estimated linear segments are presented as annual per-
centage change (APC). A summary measured over years
1990-2014 showed the annual average percent change
(AAPC) with a 95% confidence interval was calculated as a
weighted average of partial trends APCs [18].
To analyze relationships in the time period 1995-2014
between changes in macroeconomic situation and fetal,
neonatal and infant mortality, we took into consider-
ation assumed time-lag between cause and result and we
used the following linear fixed effects statistical model:
ΔY c;t− ΔY c ¼ αþ β ΔXc;t−l− ΔXc
 þ γct þ κKc;t
þ λLc;t þ εc;t
c – country
t – time (year)
l – time lag (years)
Y – dependent variable (fetal, neonatal and infant
mortality)
X – main independent variable (health expenditure
and GDP)
K, L – demographic structure variables (percentage of
people below 15 and above 65 years of age)
The model included annual changes in indicators of
mortality (standardized between countries by subtracting
country average) as a dependent variable. Main inde-
pendent variables of interest were annual changes in
macroeconomic factors (standardized between countries
by subtracting country average). Regression coefficient
for those variables (β) describes relationships between
the economic factor change and health outcome re-
sponse. We implemented time-lag from 0 to 5 years for
macroeconomic variables to account for assumed delay
between economic impulse and health outcome. Each
model also included country-specific rate of acceleration
(γc). The model was also adjusted for country demo-
graphic structure by including percentages of population
below 15 years of age and above 65 years of age. Robust
standard errors were used to account for correlation of
data within countries. Similar statistical models based on
annual changes rather than actual value of variable have
been used in other health-economic studies [19, 20].
Statistical analysis was performed using Joinpoint Re-
gression Program 4.7.0.0-2019 and IBM® SPSS® Statistics
for Windows, Version 20.0 (IBM Corp., Armonk, NY,
USA). Statistical significance (I-type error probability)
was set at α = 0.05.
Results
In the Baltic states, there were disparities in rates of
fetal, neonatal and infant mortality, with the highest
levels in Latvia in comparison to Estonia and Lithuania.
As shown by analysis of the indicators of mortality
under 1 year of age and the average annual percent de-
cline in these rates, the gaps in mortality between the
Baltic states and the EU narrowed during the years
1990-1992 and 2012-2014 (Table 1, Fig. 1). In the years
1990-2014, the largest reduction of mortality rates in the
Baltic states occurred in Estonia regarding all analyzed
mortality rates: neonatal (by 8.4% per year), infant (by
7.9% per year) and fetal (by 4.2% per year). Decrease of
mortality in Estonia led to convergence of coefficients
with the EU level. For the first time fetal mortality rate
approached in 2000, and neonatal and infant mortality
in 2002. At the end of the analyzed period in 2014, a di-
vergence of mortality patterns was found in Estonia, i.e.,
all indicators of mortality were below the EU level. In
Lithuania and Latvia, the change of mortality rate was
slower compared to Estonia, while in Lithuania neonatal
mortality rate exceeded the average of the EU in 2010,
and infant mortality rate in 2013. In Latvia, the rates of
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neonatal and infant mortality were similar to the EU
only at the end of the observation period in 2013-2014.
In the case of fetal mortality, Lithuania and Latvia in
2014 achieved slightly higher ratios than the EU level
(per 1000 total births: by 1.17 and by 0.61, respectively).
In the Baltic countries and the EU, reduction in the rate
of fetal mortality was slower compared to the neonatal
and infant mortality.
Results of the analysis of partial trends indicated the
dynamics of change in the Baltic states and the EU, es-
pecially in neonatal and infant mortality (Fig. 1). In the
initial period from 1990 until the turn of 1992/1993, in-
significant mortality trends were observed in Estonia
(neonatal, infant), Latvia (fetal, infant), while in
Lithuania the trend of infant mortality by 27.9% per year
increased significantly. After 1993, there were decreasing
mortality trends in all Baltic countries, but in Lithuania
until 1998, neonatal and infant mortality was decreasing
at the fastest rate (by 11.1% per year and by 10.3% per
year, respectively). In Latvia, after 2012, the rates of in-
fant mortality stagnated.
Compared to the EU, the Baltic states had relatively
low health expenditure and GDP per capita, given the
best macroeconomic situation occurred in Western Eur-
ope, i.e. Austria, Germany, Luxembourg (Table 2). In the
observed period 1995–2014, health expenditure and
GDP increased in all EU countries, but its pace differed
between EU countries. The largest increase in health ex-
penditure and was recorded in Romania and Bulgaria,
slower growth was observed in Greece and Italy. In the
Baltic states GDP increased by as much as 7-fold, the
smallest increase occurred in Germany and United
Kingdom.
As shown in Table 3, macroeconomic factors were as-
sociated with mortality under 1 year of age. The rela-
tionships between the change in health expenditure and
the change in fetal mortality persisted over 5 years, but
the strongest reduction in fetal mortality associated with
the annual increase in health expenditure occurred with
an interval of 4 years following the initial change (β = −
0.1544 per 100 US$ increase). Reduction in fetal mortal-
ity also occurred with an annual increase in GDP after a
5-year delay (β = − 0.0026 per 100 US$ increase). Lag
analysis of health expenditure showed that these associa-
tions with neonatal mortality were significant and main-
tained for 4 years, and the relationship with GDP was in
year 0 to 1, and 4 to 5 years. The strongest effect of re-
ducing neonatal mortality was related to the annual in-
crease in health expenditure which occurred in the same
year (β = − 0.1641 per 100 US$ increase), a similar rela-
tionship in the same year was also found with GDP (β =
− 0.0049 per 100 US$ increase). The change in the size
of the health expenditure effect was associated with in-
fant mortality in the same year (β = − 0.0788 per 100
US$ increase) and changes in GDP did not occur in sig-
nificant relationships with infant mortality.
Discussion
Mortality under 1 year of age significantly decreased in
all countries, and a convergence of the rates continued
to be observed between the Baltic states and EU-28. This
convergence occurred most rapidly in Estonia, where the
rates of fetal mortality exceeded the data for EU-16 in
2000 for the first time ever, and the neonatal and infant
mortality − in 2002. In subsequent years, the trend to di-
vergent values was observed. In Lithuania, the
Table 1 Changes in mortality under one year in the Baltic States and the European Union, 1990–2014













Estonia 8.31 3.35 −4.2* (− 4.9, − 3.4) 2.77 − 0.58
Latvia 8.53 5.34 −2.6* (− 3.5, −1.8) 2.99 1.41
Lithuania 6.82 4.38 −2.1* (−2.7, −1.5) 1.28 0.45
EU-16 5.54 3.93 −1.7* (− 1.9, − 1.5)
Neonatal mortality rate
[n/1000 live births]
Estonia 9.50 1.60 −8.4* (−9.4, −7.5) 3.83 −0.94
Latvia 10.70 (1991-1992) 3.18 −5.9* (−6.7, −5.2) 5.03 0.64
Lithuania 11.05 (1991-1992) 2.35 −6.3* (−7.1, −5.5) 5.38 − 0.19
EU-28 5.67 2.54 −3.6* (−3.8, −3.4)
Infant mortality rate
[n/1000 live births]
Estonia 13.37 2.69 −7.9* (−8.8, −7.0) 3.88 −1.05
Latvia 15.66 4.84 −5.6* (−6.4, −4.8) 6.17 1.10
Lithuania 13.70 3.81 −5.5* (−6.2, −4.8) 4.21 0.07
EU-28 9.49 3.74 −4.0* (− 4.2, −3.8)
EU-16: Austria, Czech Republic, Denmark, Estonia, Finland, Germany, Hungary, Ireland, Italy, Latvia, Lithuania, Netherlands, Poland, Portugal, Slovenia, and
United Kingdom
*Statistically significant trend at p < 0.05
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convergence of mortality patterns occurred slightly later,
the neonatal mortality rate exceeded the average of EU
in 2010, while that of infant mortality did so in 2013. In
Latvia, the mortality rate approached the average EU
level at the end of the analyzed period, but did not yet
exceed it. Time-lag analyses suggested that in the EU
countries the increase in health expenditure and GDP
was linked to a reduction fetal mortality with the stron-
gest effects after a 4 and 5-year delay. Growth of health
expenditure and GDP diminished neonatal mortality, es-
pecially in the same year.
The evidence changes related to decrease in mortality
under 1 year of age in the Baltic states was reported by
Rajaratnam et al., showing a decline in rates of neonatal
Fig. 1 Mortality under one year of age in the Baltic States and the European Union, 1990-2014. (A) Fetal mortality. (B) Neonatal mortality (data
were not available in year 1990 for Latvia and Lithuania). (C) Infant mortality
EU-16: Austria, Czech Republic, Denmark, Estonia, Finland, Germany, Hungary, Ireland, Italy, Latvia, Lithuania, Netherlands, Poland, Portugal,
Slovenia, United Kingdom
*Statistically significant trend at p < 0.05
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and infant mortality in a cross-comparison across 21 re-
gions of the world [5]. There have also been published
studies reporting inconsistent results or suggesting op-
posite trends in fetal mortality, being either decreasing
or increasing [3, 15, 21]. In all the Baltic states, following
the political and economic transformation, the Program
of Perinatology was successfully started with the essen-
tial financial support of the Swiss government. Thereby,
implemented organizational and structural changes in
mother and neonatal care, including intensive care units
and medical transport system, have significantly im-
proved birth outcomes [14, 22]. There was a possibility
that the preponderance regarding better birth outcomes
in the Baltic states compared with the rest of EU re-
sulted, at least partly, from a close cooperation with
Scandinavian experts in the field and shared principles
of good clinical practice in the perinatal and obstetric
care [14]. Nordic countries have prominent results on
maternal and child health indicators, and low neonatal
mortality rates [5, 8, 23, 24]. Noticeably, in Estonia the
mortality rates under 1 year of age decreased most rap-
idly suggesting some country-specific factors. One of the
possible explanations was the alleviation of income in-
equality and some beneficial effects of the maternal
Table 2 Macroeconomic factors in the European Union countries in year 1995 and year 2014
Calendar year Health expenditure
[PPP in US$ per capita]
Gross Domestic Product
[current international US$ per capita]
1995 2014 1995 2014
Austria 2250 5039 30,253 51,323
Belgium 1714 4392 28,566 47,439
Bulgaria 290 1399 1554 7853
Croatia 549 1652 4795 13,467
Cyprus 731 2062 15,098 27,341
Czech Republic 898 2146 5765 19,745
Denmark 1875 4782 35,351 62,426
Estonia 397 1668 3044 19,941
Finland 1480 3701 26,273 49,915
France 2102 4508 27,038 42,955
Germany 2280 5182 31,730 47,903
Greece 1267 2098 12,959 21,674
Hungary 659 1827 4481 14,118
Ireland 1193 3801 19,177 55,503
Italy 1559 3239 20,596 35,397
Latvia 221 940 2329 15,725
Lithuania 332 1718 2169 16,555
Luxembourg 2189 6812 52,831 119,173
Malta 899 3072 9114 26,181
Netherlands 1800 5202 28,885 52,157
Poland 407 1570 3683 14,342
Portugal 1017 2690 11,783 22,078
Romania 184 1079 1660 10,020
Slovakia 505 2179 4799 18,595
Slovenia 972 2698 10,691 24,021
Spain 1193 2966 15,430 29,600
Sweden 1745 5219 29,914 59,180
United Kingdom 1350 3377 22,756 46,412
EU-28 1442 3519 19,833 36,552
PPP Purchasing Power Parity, US$ United States dollars
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educational level [11, 25]. It is worth emphasizing that
Estonia also significantly improved the health status of
adult women as a result of health care activities and re-
duction of harmful lifestyle factors [26], which could
have contributed to the improvement of birth outcomes.
This dynamic evolution in Estonia after 2006 led to the
divergent rates of mortality under 1 year of age with the
EU, and Estonia achieving the level similar to the high-
income countries. The divergence noted in Estonia pro-
vides some assumption that such a continuous improve-
ment is also possible in Lithuania and Latvia.
The general health status among the population was
worsening in the early 90’s. After 1994, the situation
turned into an improvement, but there was still a signifi-
cant gap between the Baltic states and the EU in health
status. In the Baltic countries mortality due to cardiovas-
cular diseases, cancer, and suicides reached the highest
rates in comparison with other EU countries [27, 28].
Significant improvements in perinatal and children
health in the Baltic region give hope for faster improve-
ment as well in the health of the whole population.
Our results showed that there is a concern about a
slower velocity of the fetal mortality reduction compared
to the neonatal and infant mortality in the Baltic coun-
tries and the EU. Around 80% cases of fetal deaths are
antepartum stillbirths and that could be associated with
a delay in the first antepartum visit or suboptimal care,
and coincident poor socioeconomic status and harmful
factors such as smoking [29, 30]. Our results showed
that in the EU countries, capability to further the reduc-
tion of fetal and neonatal mortality through healthcare
activities are still present. Moreover, an increase in GDP
can bring benefits with improved fetal and neonatal
health. A possible explanation of the results is that GDP
growth contributes to an overall increase of socioeco-
nomic resources, and to the increase of socio-economic
status. With the larger GDP growth, countries are more
likely to implement health care programs that improve
fetal and neonatal health. These factors may be modifi-
able to a great measure, basically through the targeted
prevention programs in the health care system and high
quality hospital care services [26, 30–32]. In addition,




Expected impact of 100 US$ per capita annual rise in health
expenditure on mortality (β with 95% CI)
Expected impact of 100 US$ per capita annual rise in
GDP on mortality (β with 95% CI)
Fetal mortality
0 −0.0972 (−0.1698, −0.0246)** −0.0023 (−0.0052, 0.0006)
1 −0.1139 (−0.1825, −0.04531)*** −0.0015 (−0.0044, 0.0001)
2 − 0.1241 (− 0.1932, − 0.0549)*** − 0.0020 (− 0.0046, 0.0006)
3 − 0.1408 (− 0.2149, − 0.0666)*** −0.0020 (− 0.0051, 0.0012)
4 − 0.1544 (− 0.2072, − 0.0101)*** −0.0027 (− 0.0057, 0.0003)
5 − 0.1338 (− 0.1865, − 0.0811)*** −0.0026 (− 0.0048, − 0.0004)*
Neonatal mortality
0 − 0.1641 (− 0.2298, − 0.0985)*** −0.0049 (− 0.0068, − 0.0030)***
1 −0.1325 (− 0.2016, − 0.0633)*** −0.0045 (− 0.0064, − 0.0025)***
2 −0.0567 (− 0.1036, − 0.0099)* −0.0003 (− 0.0019, 0.0014)
3 − 0.1156 (− 0.1860, − 0.0452)*** −0.0018 (− 0.0040, 0.0004)
4 − 0.1110 (− 0.1801, − 0.0419)** −0.0027 (− 0.0043, − 0.0010)***
5 −0.0734 (− 0.1496, 0.0028) −0.0026 (− 0.0044, − 0.0001)**
Infant mortality
0 − 0.0788 (− 0.1212, − 0.0364)*** −0.00003 (− 0.0014, 0.0013)
1 0.0330 (− 0.0072, 0.073) −0.0021 (− 0.0055, 0.0013)
2 0.0102 (− 0.0384, 0.0589) −0.0001 (− 0.0014, 0.0013)
3 − 0.0100 (− 0.0540, 0.0339) 0.0010 (− 0.0012, 0.0031)
4 −0.0269 (− 0.0779, 0.0242) −0.0002 (− 0.0020, 0.0017)
5 0.0174 (− 0.0376, 0.0723) 0.0001 (− 0.0011, 0.0012)
β – the impact of annual changes in health expenditure and GDP on mortality controlling for population structure (proportion of population below 15 years of
age and proportion of population above 65 years of age) and controlling for inter-country differences in health expenditure and GDP
***p ≤ 0.001; **p ≤ 0.01; *p ≤ 0.05
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the parallel investments in social policies and education
for young women and families at high risk are important
[4, 33–35]. It is important to mention that the fetal and
neonatal health is an investment to the general health of
the entire society and therefore may considerably influ-
ence and shape the health status of future generations.
Strengths and limitations
The strong side of this study was a focus on core indica-
tors from Euro-Peristat used for the monitoring of tra-
jectories mortality under 1 year of age in the Baltic
states and the EU in the 25-year period (from 1990 to
2014). This study showed the areas of progress in fetal,
neonatal and infant health in all countries, and also from
year 2012, stagnation in the rate of infant mortality in
Latvia and neonatal mortality in the EU. In addition, the
strong side of the paper is comparability of mortality
rate in Estonia, Latvia and Lithuania, where fetal mortal-
ity rates are lower or equal at 22 weeks of gestational
age. However, in the investigated countries the recorded
stillbirths exclude abortions of pregnancy which are re-
corded in another system [8, 9]. The above uniform cri-
teria allows addressing the issue whether the decreasing
trend of fetal mortality resulted from the decrease of
stillbirth cases or because of the decreasing trend of ter-
minating pregnancies. The study revealed that while ex-
cluding from our analysis 12 countries of the EU and
using the data recording the criterion of over 22 weeks
of gestation, the trend of fetal mortality rates decreased
in EU-16 and those trends were similar to the Baltic
states. In the EU-28, the trend remained stable [7] which
caused us to conclude that exclusion of 12 countries
gave the possibility for more exact estimation of similar-
ities in fetal mortality trends, and converging or diver-
ging trajectories between the Baltic countries and the
EU.
This study showed important implications for policy;
that improving the macroeconomic situation appears to
diminish mortality under 1 year of age in the EU. It is
important in terms of low fertility levels and may be a
guide in the decision-making process regarding the dis-
tribution of resources aimed at intervention for child
health [36]. There is a need for government action to in-
crease well-being and access to appropriate obstetric
care. These factors can contribute not only for improve-
ment in child health, but also for long-term effects
throughout the lifecycle related to better adult health
and increased productivity in the labor market.
A limitation of the study is the issue of data quality
over time. The possibility of mismatches is still pos-
sible; even if mortality data and statistical information
in the Baltic countries is used by the global health or-
ganizations and databases (for instance, the WHO)
and are generally considered reliable and
internationally comparable [37]. Some limitations still
could be linked with differences in definitional ar-
rangements and registration as well as hospital pol-
icies regarding delivery and neonatal unit admission;
particularly around the limits of viability in EU coun-
tries [24, 38]. Other issue is the interpretation of lag-
time analysis, based on mortality and macroeconomic
factors, in which aggregated data level may have lim-
ited conclusions on potential causal relationship at an
individual level. Independent variables used in the
ecological study represent mortality and macroeco-
nomic factors observed on the population level, and
not the characteristics of individuals [39]. An increase
in health expenditure and GDP does not always trans-
late into improvement of health outcomes, although
the economic progress and stimulation was independ-
ently associated with mortality reduction. Further-
more, caution is advised while interpreting lag-time
analysis because these results may be underestimated
due to lacking or incomplete data on mortality, espe-
cially in newborns. Nevertheless, our study incorpo-
rated mortality reports from all EU countries based
on high quality standard and reliable procedures of
data collection.
In our analysis we focused on macroeconomic factors
with regard to controlling factors, however, the number
of variables potentially influencing was restricted. For in-
stance, medical services in gynaecological and obstetric
care or prevention programs have not been examined
here because of lack of adequate data. Although health
expenditure plays an important role in shaping the
health of the population, their distribution into individ-
ual categories varies between countries [6]. However, the
effectiveness of health care, particularly in the context of
improvement of perinatal and child health, appears as
important as health expenditure per se. Noticeably, a
relatively unfavourable health situation may also affect
countries with high health expenditure, e.g. US. Thus,
high expenditure may not necessarily be always pro-
jected into enhancement of public health status [5, 6].
On the other hand, it has been shown that the Baltic
states achieved strikingly good health outcomes despite
relatively low expenditures. These associations prove
that some other (or unknown) factors connected with
intervention programs and quality of health care services
may play a role in moderating the effectiveness of the
healthcare expenditure. Our results could be explained,
at least partly, by confounding effect of the differences in
clinical practice and setting, regarding the venue of de-
livery (i.e., public or private hospital, and outside of the
hospital). There is evidence that the venue of delivery is
associated with mortality under 1 year of age [40–43].
Adverse birth outcomes were prevalent rather in the
public hospitals compared with the private services.
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Noticeably, the discrepancies resulted from suboptimal
allocation of women to antenatal care in public hospitals
in terms of perinatal mortality risk and/or delayed med-
ical care [40]. Furthermore, it has been reported that un-
planned out-of-hospital birth may be associated with an
increases perinatal mortality, due to limited accessibility
to certain urgent medical interventions or inadequate
antenatal care [41–43]. Finally, the duration of the
mother’s stay in the hospital may have been associated
with birth outcomes [44], but the data were not available
in the analyses, and might be included in future research
agenda.
Conclusions
Within the last 25 years, the Baltic countries experienced
several beneficial changes regarding fetal, neonatal and
infant health, and this evolution has led to a conver-
gence with the patterns of the European Union. Further-
more, the process proceeded most rapidly in Estonia and
ultimately was reversed into the divergent trend. The in-
equalities in perinatal and child health existing between
European Union countries indicates a need of imple-
mentation of effective intervention modalities aimed to
reduce risks in prenatal and early life. These activities
may be an investment in human and social capital, and
may help reduce health inequalities resulting from the
child health improvement.
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